Cargando…
P1153: UTILITY OF THE FRAILTY SCORE FOR PREDICTING PROGNOSIS AND INDIVIDUALIZING TREATMENT INTENSITY IN ELDERLY PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA
Autores principales: | Yagi, Yu, Kanemasa, Yusuke, Sasaki, Yuki, Ishimine, Kento, Hayashi, Yudai, Mino, Mano, Ohigashi, An, Morita, Yuka, Tamura, Taichi, Nakamura, Shohei, Okuya, Toshihiro, Shimoyama, Tatsu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430924/ http://dx.doi.org/10.1097/01.HS9.0000971508.63934.8a |
Ejemplares similares
-
Hemoglobin‐platelet index as a prognostic factor in patients with peripheral T‐cell lymphoma
por: Yagi, Yu, et al.
Publicado: (2023) -
Clinical outcomes in transplant‐eligible patients with relapsed or refractory diffuse large B‐cell lymphoma after second‐line salvage chemotherapy: A retrospective study
por: Yagi, Yu, et al.
Publicado: (2023) -
Impact of pegfilgrastim approval on relative dose intensity and outcomes of R-CHOP for diffuse large B-cell lymphoma
por: Morita, Yuka, et al.
Publicado: (2022) -
Synchronous multiple primary tumors in patients with malignant lymphoma: a retrospective study
por: Yagi, Yu, et al.
Publicado: (2022) -
MO33-1 Trends in chemotherapy at our hospital and department under the COVID-19 pandemic
por: Kageyama, Akihiko, et al.
Publicado: (2021)